NewGenIVF Group (Nasdaq: NIVF) entered a definitive agreement to acquire an additional 3% equity interest in K25.ai at a US$250 million equity valuation, representing a US$7.5 million follow‑on investment after K25.ai’s community beta and early user traction.
Upon completion, NewGen’s ownership in K25.ai is expected to rise from 10% to 13%. As consideration, NewGen expects to issue about 2.5 million Class A ordinary shares, increasing total shares outstanding to roughly 5.9 million. According to NewGen, this should lift its market capitalization above the US$5 million threshold and support ongoing Nasdaq listing compliance. The new valuation implies NewGen’s existing 10% stake is worth US$25 million, versus an original investment cost of US$10 million, highlighting a significant mark‑up on its prior entry valuation of US$100 million for K25.ai.
Loading...
Loading translation...
Positive
Additional 3% K25.ai stake for US$7.5 million at US$250 million valuation
Ownership in K25.ai expected to increase from 10% to 13%
Implied value of existing 10% stake rises to US$25 million from US$10 million cost
Share issuance of approximately 2.5 million Class A shares increases total outstanding to 5.9 million, diluting existing holders
Market reaction after 3% K25.ai acquisition: NIVF -4.55% in the Jul 27 session
-4.55%
10 alerts
-4.55%Session close to close
+20.8%Peak Tracked
-21.8%Trough Tracked
$3.76MMarket Cap
0.2xRel. Volume
In the Jul 27 session, NIVF declined 4.55%, reflecting a moderate negative market reaction.
Argus tracked a peak move of +20.8% during that session.
Argus tracked a trough of -21.8% from its starting point during tracking.
Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
NIVF's recent insider activity was classified as Net Buying. Against that backdrop, the K25.ai stake...
Analysis
NIVF's recent insider activity was classified as Net Buying. Against that backdrop, the K25.ai stake increase adds an equity issuance and Nasdaq-compliance objective; dilution and platform execution remain relevant risks to monitor.
Key Figures
Additional equity interest:3%Equity valuation:US$250 millionInvestment:US$7.5 million+5 more
Issued shares for a 10% K25.ai stake while targeting a US$5 million MVLS threshold.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
The tag-matched acquisition/AI event recorded a negative 24-hour reaction despite an ownership increase and K25.ai valuation milestone.
Key Terms
class a ordinary shares, form 6-k
2 terms
class a ordinary sharesfinancial
"NewGen expects to issue approximately 2.5 million Class A ordinary shares."
Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.
form 6-kregulatory
"Further details regarding the transaction will be included in a Form 6-K"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
Follow-on investment would increase NewGen’s aggregate ownership to 13%
BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has entered into a definitive agreement to acquire an additional 3% equity interest in K25.ai at a US$250 million equity valuation.
The US$7.5 million investment follows K25.ai’s successful community beta and rapidly accelerating market traction. Upon completion, NewGen’s aggregate ownership in K25.ai is expected to increase from 10% to 13%.
As part of the consideration, NewGen expects to issue approximately 2.5 million Class A ordinary shares.Upon issuance, the Company’s total outstanding shares are expected to increase to approximately 5.9 million, strengthening its market capitalization above the US$5 million threshold and supporting ongoing Nasdaq listing compliance.
K25.ai recently entered community beta and is seeing early engagement from users and creators. The stepped-up US$250 million valuation reflects NewGen’s confidence in the platform’s AI-native approach and its potential as it scales across Asia-Pacific.
NewGen’s existing 10% stake in K25.ai has an implied value of US$25 million at the latest transaction valuation, compared with its original investment cost of US$10 million.
Alfred Siu, Founder, Chairman and Chief Executive Officer of NewGen, commented: “K25.ai’s strong community beta performance and early growth reinforce our conviction that it can become a defining AI-powered information market platform. The increase from our original US$100 million entry valuation to US$250 million reflects the company’s rapid execution, expanding ecosystem and significant market opportunity. By increasing our investment, we are deepening our participation at an important stage of K25.ai’s development while also strengthening our market capitalization position.”
Andy Cheung, Founder and Chief Executive Officer of K25.ai, commented: “The step-up to a US$250 million valuation after our community beta launch validates the platform’s early traction. NewGen’s decision to increase its stake at this higher valuation reflects confidence in our roadmap as we scale across Asia-Pacific.”
The NewGen Class A ordinary shares forming part of the consideration are expected to be issued pursuant to applicable exemptions from registration under the Securities Act of 1933, as amended. Further details regarding the transaction will be included in a Form 6-K furnished to the U.S. Securities and Exchange Commission.
K25.ai is an AI-native livestreaming and information market platform combining live content, AI-assisted market creation and resolution, and interactive watch-to-predict experiences. Built for sports, esports, entertainment, creator competitions and other permitted event categories, K25.ai is creating a new category at the intersection of livestreaming, artificial intelligence and audience participation. To learn more, visit www.k25.ai.
About NewGen
NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to , statements concerning the anticipated completion of the investment and the resulting increase in Newgen’s aggregate ownership of K25.ai from 10% to 13%; the US$250 million valuation and the implied value of NewGen’s existing stake in K25.ai; the anticipated issuance of approximately 2.5 million Class A ordinary shares as partial consideration and its expected effect on the total outstanding shares, market capitalization, and ongoing listing compliance; K25.ai’s growth prospects, and the parties’ future development plans. These forward-looking statements are based on the Company’s current expectations, estimates, projections, and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, among others: the possibility that the transaction may not be completed on the terms described or at all; the risk that the Company’s ownership in K25.ai may be diluted as K25.ai closes further investment rounds; the risk that the carrying value of the Company’s investment in K25.ai is not realized and may be impaired; risks generally associated with strategic investments; share dilution and capital markets issuance risk; and the risk that the anticipated increase in the Company's market capitalization following the share issuance depends on prevailing share price and investor sentiment, which may fluctuate, and that the Company may not achieve or sustain compliance with applicable Nasdaq listing standards notwithstanding the issuance. Additional risks are described in the Company’s Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable securities laws.
Investor Relations Contact NewGen Investor Relations ICR, LLC Robin Yang +1 (212) 537-3847 NewGenIVF.IR@icrinc.com
FAQ
What did NewGenIVF (NIVF) announce about acquiring more of K25.ai on July 27, 2026?
NewGenIVF announced a definitive agreement to buy an additional 3% of K25.ai at a US$250 million valuation. According to NewGenIVF, the US$7.5 million investment follows K25.ai’s successful community beta and accelerating market traction across Asia-Pacific.
How will the new K25.ai investment affect NewGenIVF’s (NIVF) ownership percentage?
The follow-on investment is expected to increase NewGenIVF’s ownership in K25.ai from 10% to 13%. According to NewGenIVF, this deeper stake enhances its participation in K25.ai’s AI-native livestreaming and information market platform as it scales in Asia-Pacific.
What valuation does the K25.ai deal imply for NewGenIVF’s existing NIVF stake?
The transaction implies NewGenIVF’s existing 10% K25.ai stake is worth US$25 million at a US$250 million valuation. According to NewGenIVF, this compares with its original US$10 million investment at a US$100 million entry valuation.
How many NewGenIVF (NIVF) shares will be issued for the K25.ai acquisition?
NewGenIVF expects to issue about 2.5 million Class A ordinary shares as part of the consideration. According to NewGenIVF, this will raise total shares outstanding to approximately 5.9 million following completion of the K25.ai follow-on investment.
What does the K25.ai investment mean for NewGenIVF’s (NIVF) Nasdaq listing compliance?
NewGenIVF expects the extra shares and implied valuation to push its market cap above US$5 million. According to NewGenIVF, this higher market capitalization is intended to support ongoing compliance with Nasdaq listing requirements tied to minimum market value.
Is NewGenIVF’s (NIVF) K25.ai share issuance registered under the Securities Act?
The Class A ordinary shares used as consideration are expected to be issued under applicable registration exemptions. According to NewGenIVF, additional information on the transaction will be provided in a Form 6-K furnished to the U.S. Securities and Exchange Commission.
